Skip to main content

Advertisement

Log in

Role of leptin as antioxidant in obstructive sleep apnea: an in vitro study using electron paramagnetic resonance method

  • Original Article
  • Published:
Sleep and Breathing Aims and scope Submit manuscript

Abstract

Introduction

As in obstructive sleep apnea (OSA), the chronic cycles of hypoxia and reoxygenation are thought to be conducive of oxidative stress (OS) with generation of reactive oxygen species, identifying effective mechanisms of protection against oxidant-mediated tissue damage becomes of outmost importance. Leptin’s role had been recently extended into that of participant to OS; while its exact role in this process is yet to be defined, elevated leptin levels correlate significantly with several indices of OSA disease severity such as nocturnal hypoxemia, possibly acting as a counteractive mechanism against the chronic intermittent hypoxia-related OS and serving as a marker of future risk of atherosclerotic disease. We therefore investigated leptin’s antioxidant mechanism on superoxide (O −•2 ) anions using spectrophotometry and electron paramagnetic resonance (EPR).

Methods

The O −•2 was generated by oxidation of xanthine (XAN) by xanthine oxidase (XO) in the presence of spin trap 5-diethoxyphosphoryl-5-methyl-1-pyrroline N-oxide with various concentrations of leptin (0.001, 0.01, 0.1, and 1 mg/ml) and without leptin. Signal intensity between 3,440 and 3,540 G was expressed as standard means ± SD. The activity of leptin on XO was determined by monitoring the conversion of XAN to uric acid at 293 nm using a Beckman DU 800 UV–visible spectrophotometer.

Results

Leptin added to aqueous solutions at 0.1 and 1 mg/ml concentrations was associated with a statistically significant decrease in the EPR signal due to leptin’s direct scavenging activity towards the O −•2 .

Conclusion

Leptin is an antioxidant agent of possible use as a marker of OS and future risk of atherosclerotic disease in OSA.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

Abbreviations

ROS:

Reactive oxygen species

O −•2 :

Superoxide anion radical

XO:

Xanthine oxidase

OSA:

Obstructive sleep apnea

SOD:

Superoxide dismutase

VEGF:

Vascular endothelial growth factor

EPR:

Electron paramagnetic resonance

XAN:

Xanthine

DEPMPO:

5-Diethoxyphosphoryl-5-methyl-1-pyrroline N-oxide

PBS:

Phosphate buffered saline

SOD:

Superoxide dismutase

GSH-P:

Glutathione peroxidase

GSH-R:

Glutathione reductase

References

  1. Ip M, Lam K, Ho C, Tsang KW, Lam W (2000) Serum leptin and vascular risk factors in obstructive sleep apnea. Chest 118:580–586

    Article  PubMed  CAS  Google Scholar 

  2. Wang M, Orci L, Ravazzola M, Unger RH (2005) Fat storage in adipocyte requires inactivation of leptin's paracrine activity: implications for treatment of human obesity. P N A S 120:18011–18016

    Article  Google Scholar 

  3. Zwillich C (1998) Sleep apnea and autonomic function. Thorax 53:S20–S24

    Article  PubMed  Google Scholar 

  4. Somers VK, Dyken ME, Clary MP, Abboud FM (1995) Sympathetic neural mechanisms in obstructive sleep apnea. J Clin Invest 96:1897–1904

    Article  PubMed  CAS  Google Scholar 

  5. Phipps PR, Starritt E, Caterson GRR (2002) Association of serum leptin and hypoventilation in human obesity. Thorax 57:75–76

    Article  PubMed  CAS  Google Scholar 

  6. O’Donnell CP, Schaub CD, Haines AS, Berkowitz DE, Tankersley CG, Schwartz AR, Smith PL (1999) Leptin prevents respiratory depression in obesity. Am J Respir Crit Care Med 159:1477–1484

    PubMed  Google Scholar 

  7. Chin K, Shimizu K, Nakamura T, Narai N, Masuzaki H, Ogawa Y, Mishima M, Nakamura T, Nakao K, Ohi M (1999) Changes in intraabdominal visceral fat and serum leptin levels in patients with obstructive sleep apnea syndrome following nasal continuous positive airway pressure therapy. Circulation 100:706–712

    Article  PubMed  CAS  Google Scholar 

  8. Harsch IA, Konturek PC, Koebnick C (2003) Leptin and ghrelin levels in patients with obstructive sleep apnoea: effect of CPAP treatment. Eur Respir J 22:251–257

    Article  PubMed  CAS  Google Scholar 

  9. Zhang Y, Proenca R, Maffei M, Barone M, Leopold L, Friedman JM (1994) Positional cloning of the mouse obese gene and its human homologue. Nature 372:425–432

    Article  PubMed  CAS  Google Scholar 

  10. Park HY, Kwon HM, Lim HJ, Hong BK, Lee JY, Park BE, Jang Y, Cho SY, Kim HS (2001) Potential role of leptin in angiogenesis: leptin induces endothelial cell proliferation and expression of matrix metalloproteinases in vivo and in vitro. Exp Mol Med 33:95–102

    Article  PubMed  CAS  Google Scholar 

  11. Guerre-Millo M, Grosfeld A, Isaad T (2002) Leptin is a hypoxia-inducible gene. Obes Res 8:856

    Article  Google Scholar 

  12. El Solh AA, Saliba R, Bobinski T, Grant BJ, Berbary E, Miller N (2006) Allopurinol improves endothelial function in sleep apnea: a randomized controlled study. Eur Resp J 4:997–1002

    Google Scholar 

  13. Lee-Chiong T (2006) Sleep: a comprehensive handbook. Wiley-Liss, New York

    Google Scholar 

  14. Christou K, Moulas AN, Pastaka C, Gourgoulianis KI (2003) Antioxidant capacity in obstructive sleep apnea patients. Sleep Med 4:225–228

    Article  PubMed  Google Scholar 

  15. Sainz N, Rodriguez A, Catalan V, Becerril S, Ramírez B, Gómez-Ambrosi J, Frühbeck G (2010) Leptin administration downregulates the increased expression levels of genes related to oxidative stress and inflammation in the skeletal muscle of ob/ob mice. Mediators Inflamm 2010:784343

    Article  PubMed  Google Scholar 

  16. Eguchi M, Liu YI, Shin EJ, Sweeney G (2008) Leptin protects H9c2 rat cardiomyocytes from H2O2-induced apoptosis. FASEB J 75:3136–3144

    Google Scholar 

  17. Zheng J, Fang J, Yin YJ, Wang X-C, Ren An-Jing, Bai J, Sun X-J, Yuan W-J, Lin L (2010) Leptin protects cardiomyocytes from serum deprivation induced apoptosis by increasing antioxidant defense. Clin Exp Pharmacol Physiol 37:955–962

    Article  PubMed  CAS  Google Scholar 

  18. Sanchez-de-la-Torre M, Mediano O, Barcelo A, Pierola J, de la Pena M, Esquinas C et al (2012) The influence of obesity and obstructive sleep apnea on metabolic hormones. Sleep Breath (in press)

  19. Lee SD, Ju G, Choi JA, Kim JW, Yoon IY (2012) The association of oxidative stress with central obesity in obstructive sleep apnea. PMID: 21614576

  20. Phillips BG, Kato M, Narkiewicz K, Chloe I, Somers VK (2000) Increases in leptin levels, sympathetic drive, and weight gain in obstructive sleep apnea. Am J Physiol Heart Circ Physiol 279:234–237

    Google Scholar 

  21. Tatsumi K, Kasahara Y, Kurosu K, Tanabe N, Takiguchi Y, Kuriyama T (2005) Sleep oxygen desaturations and circulating leptin in obstructive sleep apnea–hypopnea syndrome. Chest 127:716–721

    Article  PubMed  Google Scholar 

  22. McArdle N, Hillman D, Beilin L, Watts G (2007) Metabolic risk factors for vascular disease in obstructive sleep apnea. AJRCCM 175:190–195

    CAS  Google Scholar 

  23. Ozata M, Uckaya G, Aydin A, Isimer A, Ozdemir IC (2000) Defective antioxidant defense system in patients with a human leptin mutation. Horm Metab Res 37:269–272

    Article  Google Scholar 

  24. Kohen R, Nyska A (2002) Oxidation of biological systems: oxidative stress phenomena, antioxidants, redox reactions and methods for their quantification. Toxicol Pathol 30:620–650

    Article  PubMed  CAS  Google Scholar 

  25. Floyd RA (1990) Role of oxygen free radicals in carcinogenesis and brain ischemia. FASEB J 4:2587–2597

    PubMed  CAS  Google Scholar 

  26. Pacher P, Nivorozhkin A, Szabo C (2006) Therapeutic effects of xanthine-oxidase inhibitors: Renaissance half a century after the discovery of allopurinol. Pharmacol Rev 58:87–114

    Article  PubMed  CAS  Google Scholar 

  27. Mackintosh RM, Hirsch J (2001) The effects of leptin administration in non-obese human subjects. Obes Res 8:462–469

    Article  Google Scholar 

  28. Schulz C, Paulus K, Lehnert H (2004) Central nervous and metabolic effects of intranasally applied leptin. Endocrinology 6:2696–2701

    Article  Google Scholar 

  29. Fridrich I (1970) Quantitative aspects of the production of superoxide anion radical by milk xanthine oxidase. J Biol Chem 245:4053–4057

    Google Scholar 

  30. Chabot F, Mitchell JA, Gutteridge JMC (1998) Reactive oxygen species in acute lung injury. Eur Respir J 11:745–757

    PubMed  CAS  Google Scholar 

  31. Prasad K, Kalra J (1993) Oxygen free radicals and hypercholesterolemic atherosclerosis: effect of vitamin E. Am Heart J 125:958–973

    Article  PubMed  CAS  Google Scholar 

  32. Knight JA (2000) Review: free radicals, antioxidants, and the immune system. Ann Clin Lab Sci 30:145–158

    PubMed  CAS  Google Scholar 

  33. Chen TI, Lai CJ, Hsieh CJ, Tsai KL, Yang KT (2011) Differences in left ventricular cardiomyocytes loss induced by chronic intermittent hypoxia between spontaneously hypertensive and Wistar–Kyoto rats. Seep Breath 15:845–854

    Article  Google Scholar 

  34. Christou K, Markoulis N, Moulas A, Pastaka C, Gourgoulianis KI (2003) Reactive oxygen metabolites (ROMs) as index of oxidative stress in obstructive sleep apnea patients. Sleep Breath 7:105–110

    Article  PubMed  Google Scholar 

  35. Schultz R, Mahmoudi S, Hattar K, Sibelius U, Olschewski H, Mayer K, Seeger W, Grimminger F (2000) Enhanced release of superoxide from polymorphonuclear neutrophils in obstructive sleep apnea. Am J Respir Crit Care Med 162:566–570

    Google Scholar 

  36. Murri M, Garcia-Delgado R, Alcazar-Ramirez L, Fernández-Ramos A, Alcaide J, Cardona F, Tinahones F (2011) Continuous positive airway pressure treatment effect on oxidative stress and circulating progenitor cell levels in sleep patients with apnea–hypopnea syndrome. Respir Care, May, 20

    Google Scholar 

  37. Ip MSM, Lam B, Chan LY, Zheng L, Tsang KWT, Fung PC, Lam WK (2000) Circulating nitric oxide is suppressed in obstructive sleep apnea and is reversed by nasal continuous positive airway pressure. Am J Respir Crit Care Med 162:2166–2171

    PubMed  CAS  Google Scholar 

  38. Dyugovskaya L, Lavie P, Lavie L (2002) Increased adhesion molecules expression and production of reactive oxygen species in leukocytes of sleep apnea patients. Am J Respir Crit Care Med 165:934–939

    PubMed  Google Scholar 

  39. Hamarat M, Yenilmez A, Erkasap N, Burhanettin I, Erinc A, Tulay K, Cavit C, Canan BD (2010) Protective effects of leptin on ischemia/reperfusion injury in rat bladder. Chin J Physiol 43:145–150

    Article  Google Scholar 

  40. Sanchez-Pozo C, Rodriguez-Bano J, Dominiguez-Castellano A (2003) Leptin stimulates the oxidative burst in control monocytes but attenuates the oxidative burst in monocytes from HIV-infected patients. Clin Exp Immunol 134:464–469

    Article  PubMed  CAS  Google Scholar 

  41. He WH, Li B, Zhu X (2010) The role and mechanism of NADPH oxidase in leptin-induced reactive oxygen species production in hepatic stellate cells. Zhonghua Gan Zang Bing Za Zhi 18:849–854

    PubMed  CAS  Google Scholar 

  42. Jian-Xiong C, Yu H , Tuo Q, Zeng H, Aschner J (2007) Leptin stimulates angiogenesis in myocardial endothelial cells: Involvement of p47phox NADPH oxidase. FASEB J 21. 372.10

  43. Xu FP, Chen MS, Wang YZ (2004) Leptin induces hypertrophy via endothelin-1–reactive oxygen species pathway in cultured neonatal rat cardiomyocytes. Circulation 110:1269–1275

    Article  PubMed  CAS  Google Scholar 

  44. Konstantinidis D, Paletas K, Koliakos G, Kaloyianni M (2009) The ambiguous role of the Na+–H+ exchanger isoform 1 (NHE1) in leptin-induced oxidative stress in human monocytes. Cell Stress and Chaperones 14:591–601

    Article  PubMed  CAS  Google Scholar 

  45. Schulz C, Paulus K, Lehnert H (2004) Central nervous and metabolic effects of intranasally applied leptin. Endocrinology 145:2696–2701

    Article  PubMed  CAS  Google Scholar 

  46. Fliedner S, Schulz C, Lehnert H (2006) Brain uptake of intranasally applied radioiodinated leptin in Wistar rats. Endocrinology 147:2088–2094

    Article  PubMed  CAS  Google Scholar 

  47. Prabhakar NR (2002) Sleep apnea. An oxidative stress? Am J Respir Crit Care Med 165:859–860

    PubMed  Google Scholar 

  48. Prabhakar NR (2001) Oxygen sensing during intermittent hypoxia: cellular and molecular mechanisms. J Appl Physiol 90:1986–1994

    Article  PubMed  CAS  Google Scholar 

  49. Jia Z, Zhu H, Misra BR, Mahaney JE, Li Y, Misra HP (2008) EPR studies on the superoxide-scavenging capacity of the nutraceutical resveratrol. Mol Cell Biochem 313:187–194

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Madalina Macrea.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Macrea, M., Martin, T., Zagrean, L. et al. Role of leptin as antioxidant in obstructive sleep apnea: an in vitro study using electron paramagnetic resonance method. Sleep Breath 17, 105–110 (2013). https://doi.org/10.1007/s11325-012-0656-8

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11325-012-0656-8

Keywords

Navigation